FDA Inspection 1271831 — IPR Pharmaceuticals, Inc.
The FDA completed an inspection of IPR Pharmaceuticals, Inc. on May 12, 2025 in Canovanas, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Canovanas, PR (United States)